175 related articles for article (PubMed ID: 37476954)
1. Regulation of the ATP-binding cassette transporters ABCB1, ABCG2 and ABCC5 by nuclear receptors in porcine blood-brain barrier endothelial cells.
Ho YS; Torres-Vergara P; Penny J
Br J Pharmacol; 2023 Dec; 180(23):3092-3109. PubMed ID: 37476954
[TBL] [Abstract][Full Text] [Related]
2. Effect of amyloid beta on ATP-binding cassette transporter expression and activity in porcine brain microvascular endothelial cells.
Shubbar MH; Penny JI
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2314-2322. PubMed ID: 30048740
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic drugs modulate ATP-Binding cassette transporter-mediated transport of amyloid beta
Shubbar MH; Penny JI
Eur J Pharmacol; 2020 May; 874():173009. PubMed ID: 32061744
[TBL] [Abstract][Full Text] [Related]
4. Constitutive androstane receptor upregulates Abcb1 and Abcg2 at the blood-brain barrier after CITCO activation.
Lemmen J; Tozakidis IE; Bele P; Galla HJ
Brain Res; 2013 Mar; 1501():68-80. PubMed ID: 23340159
[TBL] [Abstract][Full Text] [Related]
5. Pregnane X receptor upregulates ABC-transporter Abcg2 and Abcb1 at the blood-brain barrier.
Lemmen J; Tozakidis IE; Galla HJ
Brain Res; 2013 Jan; 1491():1-13. PubMed ID: 23123212
[TBL] [Abstract][Full Text] [Related]
6. Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2.
Bakhsheshian J; Wei BR; Chang KE; Shukla S; Ambudkar SV; Simpson RM; Gottesman MM; Hall MD
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20801-6. PubMed ID: 24297888
[TBL] [Abstract][Full Text] [Related]
7. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier.
Narang VS; Fraga C; Kumar N; Shen J; Throm S; Stewart CF; Waters CM
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C440-50. PubMed ID: 18524938
[TBL] [Abstract][Full Text] [Related]
9. PET-CT imaging with [(18)F]-gefitinib to measure Abcb1a/1b (P-gp) and Abcg2 (Bcrp1) mediated drug-drug interactions at the murine blood-brain barrier.
Vlaming ML; Läppchen T; Jansen HT; Kivits S; van Driel A; van de Steeg E; van der Hoorn JW; Sio CF; Steinbach OC; DeGroot J
Nucl Med Biol; 2015 Nov; 42(11):833-41. PubMed ID: 26264927
[TBL] [Abstract][Full Text] [Related]
10. Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps.
Burger H; van Tol H; Brok M; Wiemer EA; de Bruijn EA; Guetens G; de Boeck G; Sparreboom A; Verweij J; Nooter K
Cancer Biol Ther; 2005 Jul; 4(7):747-52. PubMed ID: 15970668
[TBL] [Abstract][Full Text] [Related]
11. Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human.
Warren MS; Zerangue N; Woodford K; Roberts LM; Tate EH; Feng B; Li C; Feuerstein TJ; Gibbs J; Smith B; de Morais SM; Dower WJ; Koller KJ
Pharmacol Res; 2009 Jun; 59(6):404-13. PubMed ID: 19429473
[TBL] [Abstract][Full Text] [Related]
12. Neonatal exposure to zearalenone induces long term modulation of ABC transporter expression in testis.
Koraïchi F; Inoubli L; Lakhdari N; Meunier L; Vega A; Mauduit C; Benahmed M; Prouillac C; Lecoeur S
Toxicology; 2013 Aug; 310():29-38. PubMed ID: 23707492
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk.
Campa D; Butterbach K; Slager SL; Skibola CF; de Sanjosé S; Benavente Y; Becker N; Foretova L; Maynadie M; Cocco P; Staines A; Kaaks R; Boffetta P; Brennan P; Conde L; Bracci PM; Caporaso NE; Strom SS; Camp NJ; Cerhan JR; ; Canzian F; Nieters A
Int J Cancer; 2012 Aug; 131(4):803-12. PubMed ID: 21918980
[TBL] [Abstract][Full Text] [Related]
14. Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function.
Dutheil F; Dauchy S; Diry M; Sazdovitch V; Cloarec O; Mellottée L; Bièche I; Ingelman-Sundberg M; Flinois JP; de Waziers I; Beaune P; Declèves X; Duyckaerts C; Loriot MA
Drug Metab Dispos; 2009 Jul; 37(7):1528-38. PubMed ID: 19359404
[TBL] [Abstract][Full Text] [Related]
15. Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro.
von Wedel-Parlow M; Wölte P; Galla HJ
J Neurochem; 2009 Oct; 111(1):111-8. PubMed ID: 19656257
[TBL] [Abstract][Full Text] [Related]
16. ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery.
Schulz JA; Hartz AMS; Bauer B
Pharmacol Rev; 2023 Sep; 75(5):815-853. PubMed ID: 36973040
[TBL] [Abstract][Full Text] [Related]
17. Role of two efflux proteins, ABCB1 and ABCG2 in blood-brain barrier transport of bromocriptine in a murine model of MPTP-induced dopaminergic degeneration.
Vautier S; Milane A; Fernandez C; Chacun H; Lacomblez L; Farinotti R
J Pharm Pharm Sci; 2009; 12(2):199-208. PubMed ID: 19732497
[TBL] [Abstract][Full Text] [Related]
18. Brain accumulation of sunitinib is restricted by P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and can be enhanced by oral elacridar and sunitinib coadministration.
Tang SC; Lagas JS; Lankheet NA; Poller B; Hillebrand MJ; Rosing H; Beijnen JH; Schinkel AH
Int J Cancer; 2012 Jan; 130(1):223-33. PubMed ID: 21351087
[TBL] [Abstract][Full Text] [Related]
19. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy.
Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448
[TBL] [Abstract][Full Text] [Related]
20. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]